Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 6

Role of TGF-β on cardiac structural and electrical remodeling

Authors Ramos-Mondragón R, Galindo CA, Avila G

Published 5 December 2008 Volume 2008:4(6) Pages 1289—1300


Review by Single-blind

Peer reviewer comments 3

Roberto Ramos-Mondragón, Carlos A Galindo, Guillermo Avila

Departamento de Bioquímica, Cinvestav-IPN, México

Abstract: The type β transforming growth factors (TGF-βs) are involved in a number of human diseases, including heart failure and myocardial arrhythmias. In fact, during the last 20 years numerous studies have demonstrated that TGF-β affects the architecture of the heart under both normal and pathological conditions. Moreover, TGF-β signaling is currently under investigation, with the aim of discovering potential therapeutic roles in human disease. In contrast, only few studies have investigated whether TGF-β affects electrophysiological properties of the heart. This fact is surprising since electrical remodeling represents an important substrate for cardiac disease. This review discusses the potential role of TGF-β on cardiac excitation-contraction (EC) coupling, action potentials, and ion channels. We also discuss the effects of TGF-β on cardiac development and disease from structural and electrophysiological points of view.

Keywords: transforming growth factor, ion channel, cardiac electrophysiology

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Creatine supplementation upregulates excitation-contraction coupling in C2C12 myotubes

Aida Calderón-Rivera, Ana Victoria Vega, Guillermo Avila

Journal of Receptor, Ligand and Channel Research 2010, 3:63-71

Published Date: 26 May 2010

Readers of this article also read:

Five-year review of an international clinical research-training program

Suemoto CK, Ismail S, Corrêa PCRP, Khawaja F, Jerves T, Pesantez L, Germani AC, Zaina F, Santos AC, Ferreira RJ, Singh P, Paulo JV, Matsubayashi SR, Vidor LP, Andretta G, Tomás R, Illigens BM, Fregni F

Advances in Medical Education and Practice 2015, 6:249-257

Published Date: 1 April 2015

Clinical neurorestorative progress in traumatic brain injury

Huang H, Chen L, Huang H

Journal of Neurorestoratology 2015, 3:57-62

Published Date: 20 March 2015

Bilateral lid/brow elevation procedure for severe ptosis in Kearns-Sayre syndrome, a mitochondrial cytopathy

Sebastiá R, Fallico E, Fallico M, Fortuna E, Lessa S, Herzog Neto G

Clinical Ophthalmology 2015, 9:25-31

Published Date: 22 December 2014

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T

Vascular Health and Risk Management 2014, 10:303-309

Published Date: 13 May 2014

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea

Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al

Vascular Health and Risk Management 2009, 5:1063-1073

Published Date: 11 December 2009

Beta-glucans in the treatment of diabetes and associated cardiovascular risks

Jiezhong Chen, Kenneth Raymond

Vascular Health and Risk Management 2008, 4:1265-1272

Published Date: 5 December 2008

Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case

Cédric Annweiler, Marc Paccalin, Gilles Berrut, Caroline Hommet, Christian Lavigne, et al

Vascular Health and Risk Management 2008, 4:1471-1474

Published Date: 5 December 2008


Dove Medical Press Editorial

Vascular Health and Risk Management 2008, 4:1481-1481

Published Date: 5 December 2008

Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

Serge Halimi, Anja Schweizer, Biljana Minic, James Foley, Sylvie Dejager

Vascular Health and Risk Management 2008, 4:481-492

Published Date: 6 June 2008